Item Type | Name |
Academic Article
|
Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers.
|
Academic Article
|
Travelers' diarrhea. Prevention and treatment.
|
Academic Article
|
Zaldaride maleate (a new calmodulin antagonist) versus loperamide in the treatment of traveler's diarrhea: randomized, placebo-controlled trial.
|
Academic Article
|
Traveler's diarrhea due to intestinal protozoa.
|
Academic Article
|
A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.
|
Academic Article
|
Current concepts in travelers' diarrhea: epidemiology, antimicrobial resistance and treatment.
|
Academic Article
|
Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin.
|
Academic Article
|
Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region.
|
Academic Article
|
Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries.
|
Academic Article
|
Rifaximin treatment of pathogen-negative travelers' diarrhea.
|
Academic Article
|
Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.
|
Academic Article
|
Seroprevalence of the enteroaggregative Escherichia coli virulence factor dispersin among USA travellers to Cuernavaca, Mexico: a pilot study.
|
Academic Article
|
Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.
|
Academic Article
|
Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico.
|
Academic Article
|
Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea.
|
Academic Article
|
Biochemical and genetic diversity of enterotoxigenic Escherichia coli associated with diarrhea in United States students in Cuernavaca and Guadalajara, Mexico, 2004-2007.
|
Academic Article
|
Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses.
|
Academic Article
|
Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico.
|
Academic Article
|
Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries.
|
Academic Article
|
A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico.
|
Academic Article
|
Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico.
|
Academic Article
|
PCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea.
|
Academic Article
|
Epidemiology of cryptosporidiosis in North American travelers to Mexico.
|
Academic Article
|
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.
|
Academic Article
|
Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico.
|
Academic Article
|
Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico.
|
Academic Article
|
Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience.
|
Academic Article
|
Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone.
|
Academic Article
|
A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico.
|
Academic Article
|
Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico.
|
Academic Article
|
Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico.
|
Academic Article
|
Characterization of norovirus-associated traveler's diarrhea.
|
Academic Article
|
Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico.
|
Academic Article
|
A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers' diarrhea in Mexico during the dry season.
|
Concept
|
Travel
|
Academic Article
|
Enteropathogens and chronic illness in returning travelers.
|
Academic Article
|
Seroepidemiology of norovirus-associated travelers' diarrhea.
|
Academic Article
|
Persistent abdominal symptoms in US adults after short-term stay in Mexico.
|
Academic Article
|
Onchocerciasis in an expatriate living in Cameroon
|
Academic Article
|
Evaluation of a New Latex Agglutination Test for Fecal Lactoferrin in Travelers' Diarrhea
|